Wedbush initiated coverage on Rocket Pharmaceuticals with a new price target

12/30/24 7:26:29 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Wedbush initiated coverage of Rocket Pharmaceuticals with a rating of Outperform and set a new price target of $32.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$RCKT

Date	Price Target	Rating	Analyst
5/30/2025	$5.00	Outperform → In-line	Evercore ISI
5/28/2025		Overweight → Neutral	Analyst
5/28/2025	$2.00	Neutral → Sell	Goldman
5/28/2025	$8.00	Outperform → Market Perform	Leerink Partners
5/28/2025	$2.50	Buy → Hold	Jefferies
5/28/2025	$7.00	Overweight → Equal-Weight	Morgan Stanley
5/27/2025		Buy → Hold	TD Cowen
5/27/2025		Buy → Hold	Needham